Paxillin 抗体 (pTyr31)
Quick Overview for Paxillin 抗体 (pTyr31) (ABIN7468713)
抗原
See all Paxillin (PXN) 抗体适用
宿主
克隆类型
标记
应用范围
质量等级
-
-
抗原表位
- pTyr31
-
交叉反应
- 人
-
纯化方法
- Purified by antigen-affinity chromatography.
-
免疫原
- Carrier-protein conjugated synthetic peptide surrounding phospho Tyr31 of human Paxillin. The exact sequence is proprietary.
-
亚型
- IgG
-
-
-
-
应用备注
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
说明
-
Positive Control: A431 (100μM pervanadate 30min) , HeLa Validation: KO/KD, Orthogonal
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.77 mg/mL
-
缓冲液
- 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.025 % ProClin 300
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- Paxillin (PXN)
-
别名
- paxillin
-
背景
- Paxillin
-
分子量
- 65 kDa
-
基因ID
- 5829
-
UniProt
- P49023
-
途径
- MAPK Pathway, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
抗原
-